ABSTRACT The functions of gene regulatory networks that control embryonic cell diversification occur on a background of constitutively active molecular machinery necessary for the elaboration of genetic interactions. The essential roles of subsets of such "housekeeping" genes in the regulation of specific aspects of development have become increasingly clear. Pre-mRNA processing is essential for production of functional transcripts by, for example, excision of introns. We have cloned the zebrafish toast b460 locus and found that it encodes splicing factor 3b, subunit 1 (sf3b1). The sf3b1 b460 mutation causes aberrant splicing of sf3b1 resulting in functional and predicted nonfunctional transcripts and a 90% reduction in full-length Sf3b1 protein. The sf3b1 b460 mutation was isolated in a mutagenesis screen based on the absence of neural crest-derived melanophores. Further analysis revealed specific earlier defects in neural crest development, whereas the early development of other ectodermal populations appears unaffected. The expression of essential transcriptional regulators of neural crest development are severely disrupted in sf3b1 b460 mutants, due in part to defects in pre-mRNA processing of a subset of these factors, leading to defects in neural crest sublineage specification, survival and migration. Misexpression of a subset of these factors rescues aspects of neural crest development in mutant embryos. Our results indicate that although sf3b1 is a ubiquitously essential gene, the degree to which it is required exhibits tissuetype specificity during early embryogenesis. Further, the developmental defects caused by the sf3b1 b460 mutation provide insights into genetic interactions among members of the gene regulatory network controlling neural crest development.
Introduction
The removal of introns from pre-mRNA is essential for the ultimate generation of functional proteins. The precise excision of introns is catalyzed by a dynamic protein complex called the spliceosome (Burge et al., 1999) . Major elements of the spliceosome include the U1, U2, U5 and U4/6 small nuclear ribonucleoprotein particles (snRNPs) that contain small nuclear RNAs, common Sm proteins and proteins unique to each snRNP (Kambach et al., 1999) . The U2 snRNP exists in an inactive 12S form and an active 17S form generated by interaction of the 12S snRNP with the splicing factors Sf3b and Sf3a that are themselves comprised of several subunits (Brosi et al., 1993a (Brosi et al., , 1993b . Sf3b1 is the largest subunit et al., 1996) . Differentiated neural crest-derived melanophores are completely absent in tst b460 embryos (Fig. 1 ). In contrast, melanized pigmented retinal epithelial cells are present suggesting that, among pigment cells, the mutant phenotype is neural tst b460 mutation is recessive and tst b460 mutants CNS cell death and the absence of circulation.
The tst b460 locus encodes sf3b1 and is a hypomorphic sf3b1 mutant allele
We mapped the tst b460 mutation to chromosome 9 using standard tst b460 locus ( been completely sequenced by the Sanger Center (http://www.ebi.
eral genes within this region using GENESCAN (http://genes.mit. In a screen for mutations affecting neural crest development (Henion et al., 1996) , we isolated the toast b460 (tst) mutant based on the absence of neural crest-derived pigment cells but presence of the non-neural crest-derived pigmented retinal epitst tst (hpf), presumably due to prominent dorsal CNS cell death and -tion of the tst b460 locus and a detailed phenotypic analysis of the tst b460 as a hypomorphic mutant allele of sf3b1 that results in a dramatic reduction in wild-type transcripts and protein. As a result of a T>G sf3b1, pre-mRNA splicing errors in tst mutant sf3b1 result in the production of 3 aberrant, presumably non-functional transcripts as well as a minority proportion of wild-type transcripts. The primary consequences of the tst b460 mutation in the ectoderm are selective defects in neural crest development during early embryogenesis. These defects initially present as defects in the levels of expression of pre-mRNA splicing producing severely truncated transcripts. Partial restoration of a subset of these transcriptional regulators by misexpression results in differential degrees of neural crest phenotype rescue. Our results demonstrate differential sensitivities to the levels of expression of the essential RNA processing gene sf3b1 in different subdivisions of the ectoderm and among genes that control the early development of the neural crest. These cellular machinery is an additional regulatory component in the SSLPs (z21824, z54324, z60982 and z35323) and SSCPs (zk83M22T7, ctg9339_566337, zk83M22SP6 and zv4.5) be sf3b1 and that the allele is hypomorphic.
Results
To further assess whether the tst b460 mutant locus is sf3b1, we constructed the full-length wildtype cDNA for misexpression pending). Because of the large size of the predicted full-length cDNA (4393 bp), we constructed the full-length cDNA from two Methods). The presumptive full-length wildtype sf3b1 cDNA was et al
The hsp>sf3b1 expression construct was injected into a single blastomere of 1-2 cell stage embryos derived from tst b460 at 6-7hpf and 11-12hpf and raised to 27-36hpf. In a subset of 23-24hpf. No phenotypic differences were observed between were examined for visible melanophores at 27-36hpf and geno- (lane2) 
A B C D E F G H I
The full-length sf3b1 is 4393 bp derived from 25 exons. The sf3b1 cDNA predicts a protein comprised of 1315 amino acids. The Sf3b1 is highly conserved when compared to the human, mouse and Xenopus Sf3b1 homologs Sf3b1 Fig. 1 ). In addition, the amino acid sequences of C. elegans and S. pombe Sf3b1 also show a high degree of conservation compared to vertebrates (Isono et al sf3b1 we sf3b1 and performed wholemount in situ and not shown). We found using WISH that sf3b1 is maternally PCR and Western analyses ( Fig. 6 H,I ). Zygotically, in general, we found that sf3b1 mRNA is expressed ubiquitously at all stages examined (Fig. 6 C-G). Expression levels appear enhanced in the embryos (Fig. 6 E-G), although this observation may be the result of differences in the cellular composition and architecture of these regions at these stages compared to other regions of the embryo. No qualitative differences in the pattern or level of sf3b1 mRNA expression between wildtype and sf3b1 b460 mutant embryos were sf3b1 b460 mutants.
The development of neural crest-derived cell subpopulations fails in sf3b1 b460 mutant embryos As stated previously, a prominent visible phenotype ofsf3b1 b460 mutant embryos is the complete absence of differentiated neural crest-derived melanophores (Fig. 1) . Therefore, we examined the development of melanogenic precursors in sf3b1 b460 mutant embryos. To assess melanogenic sublineage development, we examined the expression of mitfa, a gene necessary for precursors (Opdecamp et al et al., 1999) and dct, whose expression is diagnostic of later stage melanoblasts (Kelsh et al mitfa in sf3b1 b460 mutant embryos is delayed by several hours and then wildtype embryos ( Fig. 7 A,B) . In contrast, the timing and pattern of PRE expression is qualitatively normal. The expression of neural crest dct dct+ cells in case for mitfa, PRE dct expression in sf3b1 b460 mutants was not sublineage is severely disrupted in sf3b1 b460 mutants resulting in the absence of differentiated melanophores.
We also assessed the development of neural crest-derived et al., 1994) and dhand (Yelon et al the developing pharyngeal arches in wildtype and sf3b1 b460 mutant embryos. We found that neural crest expression of both genes in the pharyngeal arches was dramatically reduced in mutant embryos, being absent in posterior arches and strongly reduced in the development of the neural crest component of the pharyngeal arches is severely compromised in sf3b1 b460 mutants. Another subpopulation of neural crest-derived cells that is specisubset of cranial ganglion neurons (Schilling and Kimmel, 1994) . Other neurons that comprise the cranial ganglia are derived from the ectodermal placodes. In sf3b1 b460 mutants, the numbers of neurons and organization of trigeminal ( Fig. 7 K-N) and posterior lateral line ganglia (not shown) are reduced and disorganized, respectively, compared to wildtype siblings. Although we cannot be sure that this phenotype results from a selective disruption of cranial neural crest development, as opposed to a disruption of placode development, the pattern of pan-neural crest crestin expression in the head at 22hpf (Fig. 7 O mutants. We also examined the expression of the neural crest crestin et al At 12.5hpf, the expression of crestin is nearly absent in the sf3b1 b460 mutant embryos, whereas expression is present -opment, at 22hpf, crestin mutant embryos although by noticeably fewer cells and, other the same stage, and qualitatively in contrast to earlier embryonic stages, cranial neural crest expression of crestin is nearly absent in sf3b1 b460 mutant embryos (Fig. 7 O,P) . At 11hpf, the expression of foxd3 neural crest in sf3b1 b460 mutant embryos, whereas expression by cranial neural crest is very similar to that observed in wildtype embryos (Fig. 9 A,B) . The expression of sox9b at 13hpf is also lesser extent in cranial neural crest in sf3b1 b460 mutant embryos ( Fig. 9 E,F) , an abnormal neural crest expression pattern similar to that of foxd3 cranial neural crest expression of snai1b at 12 hpf and 15 hpf and sox10 at 16hpf is evident in wildtype embryos (Fig.  9 G,I ,K). The expression of both genes in sf3b1 b460 mutant was similar but slightly reduced in cranial neural crest (Fig.  tfap2a was indistinguishable between sf3b1 b460 mutant and wildtype embryos (Fig. 9 M,N) . In contrast, a noticeable reduction in neural crest expression of tfap2a is evident in sf3b1 b460
The abnormal neural crest expression patterns of foxd3, sox9b, snai1b and sox10 observed at earlier developmental stages in sf3b1 b460 (not shown). The fact that neural crest tfap2a expression is initially normal indicates that neural crest induction occurs normally in sf3b1 b460 mutants. Thus, the neural crest expression of multiple other transcriptional regulators of neural crest development are disrupted in sf3b1 b460 mutant embryos in an asynchronous manner and share a comparatively more phenotype. As these transcription factors have been implisurvival and/or migration, these results suggest that the sf3b1 b460 mutants is, at least in part, a consequence of the disregulated expression of early transcriptional regulators of neural crest development.
sf3b1 is required cell autonomously for neural crest development
To determine whether or not sf3b1 function is required cell autonomously for neural crest development, we analyzed genetically mosaic embryos generated by cell transplantation between mutant and wildtype embryos. Because sf3b1 b460 -lanophores, we scored mosaic embryos for the presence or absence of donor-derived melanophores. Embryos generated from crosses of sf3b1 b460 heterozygous adults were separated into two groups, half of which were injected at the 1-4 cell stage with et al embryos were grown to 24-36hpf when the visible phenotype of absent melanophores in sf3b1 b460 mutant embryos is readily apdescribed previously. We found that wildtype donor neural crest cells readily generate melanophores in sf3b1 b460 sf3b1 b460 mutant neural crest cells generated melanophores in wildtype sf3b1 is required cell autonomously for neural crest development. fates is disrupted in sf3b1 b460 mutants, at least in the case of the melanophore and craniofacial cartilage sublineages. to wildtype embryos.
Increased neural crest apoptosis and migratory defects in
We then examined cell death during development in sf3b1 b460 development (12-14hpf) the numbers of dying cells in mutants is moderately increased compared to wildtype embryos, particularly positive cells along the dorsal neural tube of mutant embryos, but not wildtype embryos, are observed. We employed WISH with crestin of 17.5hpf embryos previously co-labeled with crestin indicating increased neural crest cell death in sf3b1 b460 mutants compared to wildtype siblings ( Fig. 11 A-C) .
processed embryos, we observed a progressive wave, from rostral to caudal, of substantial dorsal CNS cell death (not shown) that presumably leads to the demise of sf3b1 b460 mutant embryos by
The elevated levels of neural crest cell death in sf3b1 b460 mutant embryos raised the possibility that the abnormal development of the neural crest in sf3b1 b460 mutants results from neural crest cell apoptosis as a consequence, directly or indirectly, of abrogated misexpression of bcl2 mRNA in sf3b1 b460 -injection of 1-4 cell stage embryos resulted in a dramatic reduction sf3b1 b460 mutant embryos (Fig. 11 D,E) Whereas the neural crest expression of crestin in the head at 12.5hpf (Fig. 9 C,D) in sf3b1 b460 mutants, we found that crestin is expressed wildtype, at 22hpf (Fig. 7 O,P) . Cranial neural crest expression of crestin, in contrast to earlier stages, is nearly absent in mutants at this stage. In addition to a reduction in the number of crestin in mutants, those that are present are located predominantly along the dorsal neural tube crest migration in sf3b1 b460 mutants compared . While the extent of CNS cell death observed in sf3b1 b460 mutants, condid not observe any rescue of neural crest-derived tissues such as craniofacial cartilage anlagen or in neural crest-derived cells such as melanophores when embryos were observed between -not conclude that apoptosis plays no role in the development of the neural crest phenotype of sf3b1 b460 mutant embryos, these results strongly suggest that much of the abnormal neural crest development observed in mutant embryos results from miscues development that are dependent upon normal Sf3b1 function.
Fig. 10. Genetic mosaics of sf3b1 b460 mutants and wildtype embryos. (A) Melanophores derived from wildtype donor cells on the yolk of a sf3b1 b460 mutant host (DIC image). (B) Fluorescence image of the same (donor-derived) cells. (C) (A,B) merged. (D)

(A-C) Double labeling with TUNEL (NBT/BCIP) and crestin whole-mount in situ hybridization (fast red). Transverse section is from the trunk region of a sf3b1 b460 mutant, dorsal is up. (A) DIC image/TUNEL; (B) fluorescence image/crestin of the same section; (C) (A,B) merged. (D)
Aberrant pre-mRNA processing of a subset of transcriptional regulators of neural crest development
Because Sf3b1 is essential for pre-mRNA processing, and wildtype Sf3b1 protein levels in sf3b1 b460 mutant embryos are reduced sf3b1 itself ( Fig.  3C ; see above), we examined the pre-mRNA processing of the essential transcriptional regulators of neural crest development whose neural crest expression is abnormal in sf3b1 b460 mutant embryos ( Fig. 9; see above) . To do so, we isolated RNA from sf3b1 b460 mutant embryos and performed RT-PCR uscompared to published sequence data. We found that only normal (identical to wildtype in size and sequence) transcripts for foxd3, tfap2a and sox10 were present in sf3b1 b460 mutants suggesting that the relatively low levels of predicted functional Sf3b1 protein processing of these gene products. In contrast, we found that the pre-mRNA processing of snai1b and sox9b transcripts was severely disrupted in sf3b1 b460 mutants (Fig. 12) . In sf3b1 b460 mutant embryos, we were unable to detect normal sox9b sox9b transcript detected was devoid any protein product (Fig. 12) . While we cannot rule out the presence of small amounts of normal sox9b transcripts in sf3b1 b460 mutants present at levels below the limit of detection of methods employed, these results suggest that sf3b1 b460 sox9b functional activity. The ability to detect sox9b mRNA by WISH in sf3b1 b460 sf3b1 b460 We detected two species of snai1b transcripts in sf3b1 b460 mutants (Fig. 12) . One species corresponded to the wildtype transcript motifs found in snai1b (Thisse et al., 1995) and as such predicting that if a protein product is produced from the aberrant transcript that its function would be severely compromised. The antisense riboprobe used for WISH detection of snai1b bp (Thisse et al used would be predicted to recognize both normal and abnormal transcripts in sf3b1 b460 mutants. Therefore, the reduced levels of neural crest snai1b expression observed in sf3b1 b460 mutants protein levels. In any case, the aberrant pre-mRNA processing of Because the neural crest expression of the transcription factors foxd3, tfap2a, sox10, sox9b and snai1b are severely disrupted in sf3b1 b460 mutants and because each of these transcription factors have been shown to be differentially required for aspects of early neural crest development in multiple species including each of these genes could rescue the neural crest phenotype of sf3b1 b460 mutants when misexpressed. To do so, we individually misexpressed each transcription factor via mRNA or inducible cDNA injected into 1-4 cell stage sf3b1 b460 mutant embryos. We allowed injected embryos to develop until 36hpf and examined each for the presence or absence of differentiated melanophores, which are entirely absent in uninjected mutant embryos, followed
We found that misexpression of hs>sox10 sf3b1 b460 mutant embryos) melanophore rescue in sf3b1 b460 mutants (Fig. 13 ). In the vast majority of individual injected mutant embryos, multiple melanophores were observed -served a similar melanophore rescue when tfap2a mRNA was misexpressed in mutant embryos (Fig. 13) , although qualitatively fewer melanophores were present in each rescued mutant embryos compared to hs>sox10 injected mutants and rescue was slightly hs>sox10 injected mutants, melanophores in tfap2a injected mutants were observed in phenotype rescue activities of sox10 and tfap2a in sf3b1 b460 mutant embryos, we did not observe any differentiated melanophores in mutant embryos in which foxd3, snai1b or sox9b mRNAs were misexpressed.
Discussion
In a screen for ENU-induced mutations that result in defects et al., 1996), we isolated the tst b460 mutant based on the absence of neural crest-derived melanophores. tst b460 was found to be a recessive, embryonic lethal mutation with embryos dying at approximately Multiple lines of evidence indicate that the pre-mRNA splicing factor sf3b1 is the locus mutant in tst b460 . We found that; tst b460 maps to a critical region of chromosome 9 containing sf3b1; a BAC containing sf3b1 displayed phenotype rescue activity when misexpressed in mutant embryos; tst b460 sf3b1 contains a T>G point th intron and that tst b460 embryos defective pre-mRNA processing that are consistent with this muta- is a strong hypomorphic sf3b1 mutant thus designated sf3b1 b460 . A prominent phenotype of sf3b1 b460 mutants is the absence of neural crest-derived melanophores that is preceded by the abnormal neural crest expression of genes required for the development of and/or diagnostic of melanoblasts. This phenotype is in turn preceded by abnormal neural crest expression of transcription factors foxd3, tfap2a, snai1b, sox9b and sox10. A subset of these, sox9b and snai1b, undergo defective pre-mRNA processing while a different subset, sox10 and tfap2a, display neural crest rescue activity when misexpressed in sf3b1 b460 mutants. b460 mutant embryos with respect to the expression patterns of these transcription factors, errors in pre-mRNA processing of a subset of these and the melanogenesis rescue activity of a different subset of these transcription factors provides multiple insights into the functional interactions among these genes in regulating early neural crest development and the role of sf3b1 in this context. sox10 is reduced, parsf3b1 b460 mutants and misexpression of sox10 rescues melanogenesis in mutant embryos. Further, while sox10 pre-mRNA appears to be processed normally in mutant resulting in the complete absence of differentiated melanophores in sf3b1 b460 mutants. Because sox10 -et al crest sox10 expression levels in sf3b1 b460 prevent melanogenesis. But, since sox10 pre-mRNA processing is normal in mutants, the role of sf3b1 in the regulation of sox10 expression is indirect. Importantly, the neural crest expression of sox9b, foxd3 and tfap2a are also reduced in sf3b1 b460 mutants. Neural crest expression of sox10 has been shown to be reduced in both sox9b (Yan et al foxd3 (Montero-Balaguer et al et al foxd3;tfap2a double mutants (Arduini et al indicate that sox9b and foxd3 regulate neural crest sox10 expression while combined foxd3 and tfap2a function also synergistically regulates sox10. However, foxd3 and tfap2a transcripts are normally generated in sf3b1 b460 mutants, albeit at reduced levels or fail to be maintained, respectively. Importantly though, sox9b pre-mRNA processing is severely disrupted in sf3b1 b460 mutants leading to the absence of functional transcripts and sox9b has been shown to regulate the neural crest expression of both foxd3 and sox10 (and snai1b, see below; Yan et al neural crest tfap2a expression is dependent upon foxd3 (Stewart et al that failure in the sf3b1-dependent pre-mRNA processing of sox9b in sf3b1 b460 mutants results in downregulation of neural crest foxd3 and sox10 expression, and that the resulting reduction in foxd3 expression levels results in decreased neural crest expression of tfap2a. Thus, sf3b1-dependent pre-mRNA processing of sox9b is necessary for the establishment and/or maintenance of the transox10-dependent melanogenesis.
We also found that misexpression of tfap2a rescued melanogenesis in sf3b1 b460 mutants. While neural crest tfap2a expression is initially normal, expression is not maintained at wildtype levels. Analysis of transcripts indicates that pre-mRNA processing of tfap2a is normal in sf3b1 b460 tfap2a mutants (Knight et al et al sf3b1 b460 timeframe in which melanogenesis is delayed in tfap2a mutants.
Further, in addition to the delay in overt melanophore differentiation (pigmentation), the expression of both mitfa, and to a greater extent the levels and pattern of the expression of c-kit are also delayed in tfap2a mutants. In the latter case, c-kit required for melanoblast/melanophore migration and survival in et al., 1999) , suggesting that the reduction in tfap2a expression in sf3b1 b460 mutants could contribute to a delay in mitfa c-kitdependent melanophore migration/survival thus contributing to the sf3b1 b460 mutant melanophore phenotype that can be partially rescued upon tfap2a misexpression.
Although misexpression of snai1b in sf3b1 b460 mutants in and of itself failed to rescue the melanogenesis phenotype of mutant embryos, the fact that snai1b pre-mRNA processing is severely of neural crest snai1b expression may contribute to the overall neural crest phenotype of sf3b1 b460 mutants. Studies in multiple species indicate a role for snai1b in epithelial-mesenchymal transitions (EMT), including that which generates the premigracrest snai1b expression in sf3b1 b460 mutants, due at least in part to aberrant pre-mRNA processing, could disrupt neural crest EMT and contribute to the increased levels of neural crest apoptosis observed in mutant embryos. A consequence could be a reduction in the overall neural crest population that could contribute to the derivative phenotypes observed in sf3b1 b460 mutants. It should also be noted that while our discussion concerning neural crest derivatives has focused on melanphores with respect to the sf3b1 b460 mutant phenotype, the disruptions in the neural crest expression of the transcription factors analyzed as a consequence, directly or indirectly of disruption of Sf3b1 function, may also be involved in the development of the other neural crest derivative phenotypes including craniofacial progenitors and cranial ganglion neurons. In addition, there is a strong possibility that additional genes that regulate neural crest development, whose expression was not analyzed, may also be disrupted directly or indirectly in sf3b1 b460 mutants and contribute to the expression defects in the transcription factors analyzed and/or neural crest development.
Our results provide new insights into sf3b1 function during de- 
Materials and Methods
and staged according to Kimmel et al., 1995 . The toast b460 (tst) mutation nitrosourea) mutagenesis (Henion et al., 1996) . tst WIK lines were obtained experiments. The hi3394a (sf3b1 et al
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount single and double in situ hybridization were performed as (phosphate-buffered saline solution) at 4°C. Embryos older than 24 hpf were treated with PTU (1-phenyl-2-thiourea) to prevent melanin synthesis. Prehybridization and hybridization were carried out at 65°C. The following digoxigenin (DIG) labeled antisense RNA probes were used in single in situ hybridization: crestin et al foxd3 (Odenthal and Nussleinsnai1b (snail-2, Thisse et al., 1995) , sox10 (Dutton et al., tfap2a (Knight et al sox9b (Chiang et al dlx2, dlx3 et al., 1994 ), islet-1 (Inoue et al., 1994 ), islet-2 (Appel et al., 1995 , huC et al dct and mitfa et al., 1999), nkx2.5 et al., 1996) , and myoD (Weinberg et al., 1996) . Whole-mount double in situ hybridization was performed by using DIG labeled myoD antisense crestin antisense RNA probe as desf3b1 antisense and sense RNA probes were synthesized corresponding sf3b1 PCRIIsf3b1c construct linearized with NotI or BamHI separately and transcribed with SP6 or T7 separately. Other sf3b1 antisense and sense RNA probes were made sf3b1 PCRIIsf3b1a construct linearized with NotI and HindIII and transcribed with SP6 and T7 separately.
Immunohistochemistry was performed as described (Henion et al., 1996) .
at 4°C. Antibodies were used at the following dilutions: zn-12 (Trevarrow et al
TUNEL assays
done for 1 h on ice, followed by 1 h at 37°C. After labeling with digoxigenin development. For whole-mount in situ then, WISH was performed as described. Fast red was used for detection.
Genetic mosaic assays
Genetic mosaic assays were performed by transplanting cells between wild-type and mutant embryos at the late blastula stage as described (Ho sf3b1 b460 heterozygous carriers were divided into two groups, a donor group and a host group. 
sf3b1 cDNA cloning and misexpression analysis
The wild-type full length cDNA of sf3b1 was assembled with wild-type fb99f09. The EST clone fb99f09 (RZPD) was sequenced by PMGF at Ohio State University and it contains sf3b1 cDNA fragment which overlaps with the sf3b1 cDNA fragment sf3b1 PCRII vector (digested with XhoI/ClaI fb99f09 EST clone (digested with ClaI/XbaI) were cloned into the XhoI/XbaI site of pCS2+ vector as pCS2+sf3b1. The sf3b1 full length cDNA from construct pCS2+sf3b1 with XhoI (blunt)/XbaI site was cloned into ClaI (blunt)/XbaI pCSHSP (Halloran et al et al., hsp>sf3b1 . DNA of hsp>sf3b1 tst b460 mutant embryos and their wild-type siblings from intercrosses of the tst WIK line were injected with hsp>sf3b1 2 or 3 times at 6-7 hpf, 11-12 hpf, and 23-24 hpf time points for 1 hour at 37°C. Embryos were genotyped as described previously. hs>sox10 (Dutton et al tst mutant embryos at 1-to 2-cell stages and their wild-type siblings from intercrosses of tst described (Dutton et al Synthetic sense-polyA-capped mRNAs were transcribed in vitro from After transcription, the mRNAs were recovered as described (mMESSEGE pCS2+foxd3 (Stewart et al pCS2+tfap2a (Knight et al pCS2+sox9a, pCS2+sox9b (Yan et al pCS2+bcl2 et al NotI. The linearized DNA was used as template for in vitro transcription by SP6 polymerase. The ng/ l and injected into a single blastomere of tst b460 mutant and wild-type embryos from intercrosses of tst WIK line at the 1-to 4-cell stage. The injected embryos were scored and genotyped as described above. The embryos injected with bcl2 assay to detect programmed cell death as well as subsequently (see above) for phenotype rescue assessment.
Morpholino phenocopy analysis
Two Morpholino antisense oligonucleotides (MO) were designed and acquired from Gene Tools: sf3b1MO3rd that targets pre-mRNA splicing at the 3rd exon (ATGAATCCTCGTCATCATCCTAAA), and sf3b1ATGmo that targets the start site of sf3b1 (GGCGATCTGCGCCATTTTCGTGCTG). Each morpholino was injected separately into one blastomere of wild-type embryos at the 1-to 4-cell stage to interfere with either pre-mRNA splicing of sf3b1 morpholino injections were divided into two groups: morphants (embryos of sf3b1MO3rd against the splice site was evaluated by RT-PCR with primers sf3b1aa (46)F and sf3b1aa (579)R. Western blot with mouse Sf3b1 monoclonal antibody (Horie et al
Western blotting
Western blot analysis was performed as described (Monani et al EDTA, g of protein from different embryos (Wild-type embryos, tst b460 homozygous mutants, hi3394a homozygous mutants, sf3b1ATGmo morphants, hsp>sf3b1 injected tst b460 mutant embryos with phenotypic rescue) mixed -mercaptoethanol) was loaded transferred to nitrocellulose membranes (Whatman GmbH). TBS Blotto A antibodies for western blotting are mouse monoclonal antibodies, antiet al protein loading control (Abcam Inc.). HRP-conjugated secondary antibody was used to bind primary antibody and detected by chemiluminescence
